Learn how a biotech entrepreneur and a basic scientist pivoted their research activities to fastrack testing and a potential treatment for the COVID-19 pandemic.
Dale Chappell, MD, MBA, MED'99
Chief Scientific Officer, Humanigen
Founder, Black Horse Capital Advisors
David Leib, PhD
Chair, Department of Microbiology and Immunology
Geisel School of Medicine at Dartmouth